Collegium Pharmaceutical (COLL) Research & Development (2014 - 2022)

Collegium Pharmaceutical's Research & Development history runs 9 years deep, the most recent figure standing at $4.0 million for Q1 2022.

• In Q1 2022, Research & Development rose 35.94% year-over-year to $4.0 million; the TTM figure through Dec 2022 stood at $4.0 million (down 57.86% YoY), while the FY2022 annual figure was $4.0 million, down 57.86% from the prior year.
• Research & Development was $4.0 million for Q1 2022 at Collegium Pharmaceutical, up from $1.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $4.0 million in Q1 2022 to a low of $1.4 million in Q3 2021.
• Historically, Research & Development has averaged $2.5 million across 5 years, with a median of $2.5 million in 2019.
• Biggest YoY gain for Research & Development was 38.87% in 2021; the steepest drop was 34.91% in 2021.
• A 5-year view of Research & Development shows it stood at $2.2 million in 2018, then gained by 6.63% to $2.4 million in 2019, then rose by 3.09% to $2.5 million in 2020, then tumbled by 34.91% to $1.6 million in 2021, then jumped by 147.55% to $4.0 million in 2022.
• The last three Research & Development figures came in at $4.0 million (Q1 2022), $1.6 million (Q4 2021), and $1.4 million (Q3 2021), per Business Quant data.